Fidelity Investments’s Sana Biotechnology SANA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $92.4M | Buy |
33,833,306
+79,838
| +0.2% | +$218K | 0.01% | 1153 |
|
|
2025
Q1 | $56.7M | Buy |
33,753,468
+263,250
| +0.8% | +$442K | ﹤0.01% | 1310 |
|
|
2024
Q4 | $54.6M | Buy |
33,490,218
+1,881,043
| +6% | +$3.07M | ﹤0.01% | 1346 |
|
|
2024
Q3 | $131M | Buy |
31,609,175
+4,438,949
| +16% | +$18.5M | 0.01% | 983 |
|
|
2024
Q2 | $148M | Buy |
27,170,226
+5,127,689
| +23% | +$28M | 0.01% | 896 |
|
|
2024
Q1 | $220M | Buy |
22,042,537
+6,291,246
| +40% | +$62.9M | 0.01% | 750 |
|
|
2023
Q4 | $64.3M | Sell |
15,751,291
-147,438
| -0.9% | -$602K | ﹤0.01% | 1195 |
|
|
2023
Q3 | $61.5M | Sell |
15,898,729
-745,336
| -4% | -$2.88M | 0.01% | 1182 |
|
|
2023
Q2 | $99.2M | Buy |
16,644,065
+7,489,972
| +82% | +$44.6M | 0.01% | 995 |
|
|
2023
Q1 | $29.9M | Sell |
9,154,093
-15,317
| -0.2% | -$50.1K | ﹤0.01% | 1446 |
|
|
2022
Q4 | $36.2M | Sell |
9,169,410
-37,275
| -0.4% | -$147K | ﹤0.01% | 1386 |
|
|
2022
Q3 | $55.2M | Sell |
9,206,685
-541,989
| -6% | -$3.25M | 0.01% | 1210 |
|
|
2022
Q2 | $62.7M | Buy |
9,748,674
+512,607
| +6% | +$3.3M | 0.01% | 1166 |
|
|
2022
Q1 | $76.3M | Buy |
9,236,067
+608,216
| +7% | +$5.02M | 0.01% | 1196 |
|
|
2021
Q4 | $134M | Buy |
8,627,851
+175,107
| +2% | +$2.71M | 0.01% | 962 |
|
|
2021
Q3 | $190M | Sell |
8,452,744
-96,433
| -1% | -$2.17M | 0.02% | 824 |
|
|
2021
Q2 | $168M | Sell |
8,549,177
-186,213
| -2% | -$3.66M | 0.01% | 888 |
|
|
2021
Q1 | $292M | Buy |
+8,735,390
| New | +$292M | 0.03% | 620 |
|